Key result
Total joint replacement in patients with arthrogryposis multiplex congenita effectively improved function and significantly reduced hip pain from a mean preoperative score of 8.5 to 0.
Why the study?
Painful joint dysplasia and degeneration can develop in arthrogryposis multiplex congenita (AMC), making total joint replacement a potential treatment option, but functional outcomes, implant survivorship, and complications needed investigation.
Does total joint replacement improve function and reduce pain in patients with arthrogryposis multiplex congenita?
Case Report (n=3)
No
Does total joint replacement improve function and reduce pain in patients with arthrogryposis multiplex congenita?
Absolute Event Rate: 0% vs 8.5%
p-value: p=0.001
Total joint replacement in patients with arthrogryposis multiplex congenita is a safe procedure that effectively reduces pain and improves function, regardless of preoperative ambulatory status.
Provides early evidence of benefit from hip replacement in arthrogryposis; leaves open need for controlled trials to confirm efficacy.
INTRODUCTION: Arthrogryposis multiplex congenita (AMC) is a rare congenital condition that leads to severe joint contractures and deformities. As painful joint dysplasia and degeneration might develop over time, total joint replacement (TJR) can be a potential treatment option for these patients. The aim of this study is to investigate functional results, implant survivorship and potential complications in patients with AMC who undergo hip or knee arthroplasty. MATERIALS AND METHODS: We retrospectively identified six TJR in three patients at a single centre performed between 2006 and 2019. The median patient age at surgery was 23 years and the median follow-up period was 69 (IQR 55-99) months. We analysed surgical technique, implant survivorship and complications as well as functional outcome determined by pain reported on the Numerical Rating Scale (NRS), patient-reported outcome scores [Oxford Hip Score (OHS), Harris Hip score (HHS), Oxford Knee Score (OKS)], range of motion and ambulatory status. Depending on data distribution means with ranges and median with interquartile range were compared with the Wilcoxon signed rank test or Student's t test. The level of significance was defined at < 0.05. RESULTS: In hips, the mean range of motion in flexion/extension (52° vs. 85°, p = 0.014) and in rotation (28° vs. 68°, p = 0.02) as well as mean pain score on the NRS (8.5 vs. 0, p = 0.001), OHS (9 vs. 26, p = 0.031) and HHS (17 vs. 52, p = 0.007) significantly improved. In knees, mean range of motion (55° vs. 93°, p = 0.403), mean pain score on the NRS (0 vs. 7) and the OKS (2 vs. 21) also improved. While the ambulatory status did not change, the patients who were wheelchair dependent reported less problems with transfers to a bed or chair and the patient who ambulated reported an improved walking distance. One total knee arthroplasty (TKA) underwent revision for an acute, late infection 155 months following the initial surgery. CONCLUSIONS: TJR is a safe procedure in patients with AMC that effectively improves function and reduces pain irrespective of preoperative ambulatory status.
No takes yet. Share an insight, caveat, or question.
Theil et al. (2020) conducted a case report in Arthrogryposis multiplex congenita (AMC) (n=3). Total joint replacement (hip or knee) vs. Preoperative baseline was evaluated on Mean pain score on the Numerical Rating Scale (NRS) in hips (p=0.001). Total joint replacement in patients with arthrogryposis multiplex congenita effectively improved function and significantly reduced hip pain from a mean preoperative score of 8.5 to 0.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: